We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Omnicell Inc | NASDAQ:OMCL | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.84 | 2.87% | 30.13 | 26.37 | 82.04 | 30.74 | 29.35 | 29.87 | 865,887 | 05:00:09 |
From May 2019 to May 2024
NEW YORK, March 4, 2015 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating allegations for Omnicell, Inc. shareholders (NASDAQ:OMCL). Concerned OMCL investors who purchased between May 2, 2014 and March 2, 2015 are encouraged to contact securities attorney Hamilton Lindley by clicking here.
The law firm's investigation will focus on potential violations of the federal securities laws. Omnicell announced on March 3, 2015, that it will delay the filing of its Form 10-K with the SEC, as it looks into employee allegations that there exists a "side letter" arrangement for a specific customer for certain discounts and product provided at no cost, which is not currently reflected in final invoices. On March 3, 2015, Omnicell shares are down $2.12 per share, on this news, to $33.10, or more than 6.02%.
Dunnam & Dunnam has significant experience representing shareholders in securities lawsuits nationwide. OMCL stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@dunnamlaw.com with questions, toll free at (844) 702-2990 or visit http://www.dunnamlaw.com/OMCL.
Find these Waco personal injury attorneys, trucking accident attorneys and car wreck attorneys on Google+, Facebook, Twitter and LinkedIn.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/omnicell-inc-investors-encouraged-to-contact-securities-law-firm-about-investigation-into-allegations-of-corporate-wrongdoing-300045593.html
SOURCE Dunnam & Dunnam
Copyright 2015 PR Newswire
1 Year Omnicell Chart |
1 Month Omnicell Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
